Zn(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Five studies showed a significant reduction in CRP/hs‐CRP following zinc supplementation (SMD = −0.91; 95% CI −1.43 to −0.38; p = 0.0007), with considerable heterogeneity (I 2 = 76%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect -0.91 standardised mean difference, 95% CI -1.43 to -0.38
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Keep reading
- Everything the graph holds on Zn(2+)
- Every compound studied against C-reactive protein concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PANPWVAQG78EB0P154SVX3